Trial · NCT00075946
Participant flow25
How many started, completed or left each group, period by period.
1 to 20 of 25
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Rituximab Retreatment: Follicular Patients | 148 | |
| Overall Study | STARTED | Rituximab Scheduled: Follicular Patients | 151 | |
| Overall Study | STARTED | Rituximab Retreatment: Non-Follicular Patients | 28 | |
| Overall Study | STARTED | Rituximab Scheduled: Non-Follicular Patients | 30 | |
| Overall Study | STARTED | Enrolled But Not Randomized | 188 | |
| Overall Study | Treated and With Toxicity Data Available | Rituximab Retreatment: Follicular Patients | 142 | |
| Overall Study | Treated and With Toxicity Data Available | Rituximab Scheduled: Follicular Patients | 148 | |
| Overall Study | Treated and With Toxicity Data Available | Rituximab Retreatment: Non-Follicular Patients | 27 | |
| Overall Study | Treated and With Toxicity Data Available | Rituximab Scheduled: Non-Follicular Patients | 29 | |
| Overall Study | Treated and With Toxicity Data Available | Enrolled But Not Randomized | 154 | |
| Overall Study | Included in Primary Analysis | Rituximab Retreatment: Follicular Patients | 143 | |
| Overall Study | Included in Primary Analysis | Rituximab Scheduled: Follicular Patients | 146 | |
| Overall Study | Included in Primary Analysis | Rituximab Retreatment: Non-Follicular Patients | 23 | |
| Overall Study | Included in Primary Analysis | Rituximab Scheduled: Non-Follicular Patients | 29 | |
| Overall Study | Included in Primary Analysis | Enrolled But Not Randomized | 0 | |
| Overall Study | COMPLETED | Rituximab Retreatment: Follicular Patients | 0 | |
| Overall Study | COMPLETED | Rituximab Scheduled: Follicular Patients | 0 | |
| Overall Study | COMPLETED | Rituximab Retreatment: Non-Follicular Patients | 0 | |
| Overall Study | COMPLETED | Rituximab Scheduled: Non-Follicular Patients | 0 | |
| Overall Study | COMPLETED | Enrolled But Not Randomized | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00075946/flow